Fda 预测与赔率· 148 个市场

FDA approves Retatrutide this year?

FDA approves Retatrutide this year?

$544k 交易量
$6k 流动性
3
9 个月后结束

23%

Yes

Hyperliquid airdrop by ....?

Hyperliquid airdrop by ....?

$432k 交易量
$4k 流动性
27

37%

Yes

FDA revokes polio vaccine in Trump's first 100 days?

FDA revokes polio vaccine in Trump's first 100 days?

$44k 交易量
$0 流动性
5
已结束

No

All

Will the FDA approve any COVID-19 vaccination for children under 12 by November 1?

$127k 交易量
$0 流动性
已结束
Will any of the COVID vaccines be granted full FDA approval by September 1?

All

Will any of the COVID vaccines be granted full FDA approval by September 1?

$140k 交易量
$0 流动性
已结束
Will Pfizer's COVID-19 vaccine be the first to receive FDA approval or Emergency Use Authorization (EUA)?

All

Will Pfizer's COVID-19 vaccine be the first to receive FDA approval or Emergency Use Authorization (EUA)?

$152k 交易量
$0 流动性
已结束
Will AstraZeneca's COVID-19 vaccine receive FDA approval or Emergency Use Authorization (EUA) by May 1, 2021?

All

Will AstraZeneca's COVID-19 vaccine receive FDA approval or Emergency Use Authorization (EUA) by May 1, 2021?

$29k 交易量
$0 流动性
已结束

All

Will the FDA approve any COVID-19 vaccination for children under 12 by October 15?

$129k 交易量
$0 流动性
已结束
Will any of the COVID vaccines be granted full FDA approval by December 1?

All

Will any of the COVID vaccines be granted full FDA approval by December 1?

$7k 交易量
$0 流动性
已结束
Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?

All

Will the FDA give emergency use authorization or otherwise approve Paxlovid before 2022?

$147k 交易量
$0 流动性
已结束

All

Will the FDA give emergency use authorization or otherwise approve Molnupiravir before 2022?

$16k 交易量
$0 流动性
已结束
FDA approves Dordaviprone?

FDA approves Dordaviprone?

$14k 交易量
$0 流动性
12
已结束

Yes

FDA approves UX111?

FDA approves UX111?

$41k 交易量
$0 流动性
12
已结束

No

FDA approves EYLEA HD?

FDA approves EYLEA HD?

$6k 交易量
$0 流动性
12
已结束

No

FDA approves Donidalorsen?

FDA approves Donidalorsen?

$4k 交易量
$0 流动性
12
已结束

Yes

FDA approves FILSPARI REMS modification?

FDA approves FILSPARI REMS modification?

$1k 交易量
$0 流动性
12
已结束

Yes

FDA approves Leqembi auto-injection for early Alzheimer’s?

FDA approves Leqembi auto-injection for early Alzheimer’s?

$2k 交易量
$0 流动性
12
已结束

Yes

FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?

FDA approves Telix Pharmaceuticals’ TLX250-CDx for kidney cancer imaging?

$3k 交易量
$0 流动性
12
已结束

No

FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?

FDA approves Precigen’s PRGN-2012 for recurrent respiratory papillomatosis?

$15k 交易量
$0 流动性
12
已结束

Yes